Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte

Eric A Hanse1, Douglas G Mashek, Jennifer R Becker

  • 1Division of Gastroenterology, Hennepin County Medical Center, Minneapolis, MN, USA.

Insights

Cyclin D1 impairs liver lipogenesis by repressing key transcription factors, linking cell cycle control to metabolic regulation during liver regeneration and injury.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Metabolic Regulation

Background:

  • Liver metabolic capacity is altered post-injury during compensatory hepatocyte proliferation.
  • Mechanisms linking cell cycle progression to metabolic changes remain unclear.

Purpose of the Study:

  • To investigate the role of cyclin D1 in regulating de novo lipogenesis.
  • To elucidate the molecular mechanisms by which cyclin D1 influences lipogenic gene expression.

Main Methods:

  • Primary hepatocyte culture and gene expression analysis.
  • Study of transcription factors carbohydrate response element-binding protein (ChREBP) and hepatocyte nuclear factor 4α (HNF4α).
  • In vivo studies in mouse liver during carbohydrate feeding and regeneration.

Main Results:

  • Cyclin D1 significantly impaired glucose-stimulated lipogenesis and inhibited key lipogenic genes.
  • Cyclin D1 repressed both ChREBP and HNF4α activity, affecting their transcriptional functions.
  • Cyclin D1 inhibited HNF4α recruitment to lipogenic gene promoters via Cdk4-dependent and -independent pathways.

Conclusions:

  • Cyclin D1 acts as a repressor of ChREBP and HNF4α in hepatocytes.
  • These findings establish a direct link between the cell cycle machinery and metabolic control in the liver.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...